膵臓がん治療市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPMD00002009
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 133
Buy Now

[調査レポート]膵臓がん治療市場は、2017 年の 20 億 1,120 万米ドルから 2025 年までに 4 億 5,640 万米ドルに達すると予想されています。 2018 年から 2025 年までに 8.1% の CAGR で成長すると推定されています。膵臓がんは、膵臓内の細胞が制御不能に増殖することで始まります。影響を受ける細胞の種類に基づいて、膵臓がんは外分泌腫瘍と内分泌腫瘍の 2 つのタイプに分類できます。これらの腫瘍は異なる挙動をします。したがって、それらは異なって扱われます。膵臓がんは症状が検出または診断されにくいため、一般に後期に診断されます。膵臓の慢性炎症(膵炎)、糖尿病、喫煙、肥満などの要因は、膵臓がんの原因として確認されています。膵臓がん治療市場の成長は、膵臓がんに苦しむ患者数の増加、膵臓薬の医療費の増加、市場で発売される治療法の増加などの要因に起因すると考えられています。さらに、膵臓がん治療のための効率的な治療法の開発は、予測期間中に市場を刺激すると予想されます。しかし、治療の副作用と治療の低い成功率により、膵臓がん治療市場は抑制されることが予想されます。



膵臓がん治療の収益性の高い地域市場



市場洞察

膵臓がんに苦しむ患者数の増加



膵臓がんは、膵臓の組織で発生し、近くの臓器に急速に広がる進行性のがんの 1 つです。膵臓がんは、世界で 12 番目に多く発生するがんです。米国癌協会によると、2018 年には米国で約 55,440 人の患者が膵臓癌と診断されると予想されています。さらに、ACS はまた、膵臓癌が米国の癌に関連した死亡原因の 3 位であり、今後も膵臓癌と診断されると報告しています。英国癌研究によれば、2015 年に英国では約 9,921 人が新たに膵臓がんと診断され、8,912 人の患者が同じがんにより死亡しました。癌はほとんどの場合致死的であるため、患者には潜在的な治療法が必要です。処理。たとえば、米国癌協会は、米国のすべての癌による死亡の約 3% が膵臓癌であると示唆しています。国立衛生研究所によると、2015 年に米国で膵臓がんを患っている患者は推定 68,615 人でした。膵臓がんの発生率と有病率の増加により、患者の薬剤、治療法、治療の需要が増加すると予想されます。さらに、患者数の増加は、分子生物学と化学薬品の製剤の進歩をもたらします。したがって、膵臓がん患者の膨大な数により、今後数年間にわたって世界の膵臓がん治療市場の成長が加速すると予想されます。



タイプ インサイト



タイプに基づいて、膵臓がん治療市場は、膵内分泌がんと膵外分泌がんに分類されます。 2017 年には、外分泌膵臓がんセグメントがタイプ別に市場で最大のシェアを占めました。外分泌膵臓がんセグメントは、今後数年間で最も急速に成長すると予想されています。この種のがんは最も一般的で、最も多く発生するタイプであり、したがって、予測される数年間にわたって膨大な患者数が予想されるためです。



世界の膵臓がん治療市場、タイプ別 - 2017 年および 2025 年



治療に関する洞察



治療法に基づいて、膵臓がん治療市場は生物学的療法、化学療法などに分類されます。 2017年、生物学的療法セグメントが療法別で市場最大のシェアを占めました。さらに、生物学的療法部門は、重篤な副作用なくがんを治療し、従来の治療法を上回る多くの治療上の利点を持つ標的細胞療法や、新たに開発される免疫療法の数が増加しているため、今後数年間で最も急速に成長すると予想されています。



戦略的洞察



有機的戦略は、膵臓がん治療市場の企業がより一般的に採用する戦略であり、これにより企業は世界的な展開、製品およびサービスのポートフォリオを拡大することができます。市場関係者はまた、製品承認、臨床試験などの有機的な戦略を採用しており、その他の戦略により世界的な顧客ベースを拡大することができ、これによりブランド名を世界的に維持することも可能になります。



世界的な膵臓がん治療市場 - タイプ別





  • 外分泌膵臓がん

  • 内分泌膵臓がん


世界の膵臓がん治療市場 - 治療法別





  • 生物学的製剤治療

  • 化学療法

  • その他


世界の膵臓がん治療市場 - 地域別





  • 北米

    • 米国

    • カナダ

    • メキシコ



  • ヨーロッパ

    • フランス

    • ドイツ

    • イタリア

    • 英国

    • スペイン



  • アジア太平洋(APAC)

    • 中国

    • インド

    • 韓国

    • 日本

    • オーストラリア


  • 中東およびアフリカ (MEA)

    • 南アフリカ

    • サウジアラビア

    • アラブ首長国連邦


  • 中南米

    • ブラジル

    • アルゼンチン






会社概要





  • イーライリリーと会社

  • F.ホフマン・ラ・ロッシュ株式会社

  • アムジェン社

  • ノバルティスAG

  • セルジーン社

  • メルク社

  • < li>Pharmacyte Biotech Inc
  • Clovis Oncology

  • Teva Pharmaceutical Industries Ltd

  • ファイザー Inc

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Eli Lilly and Company
2. F. Hoffmann-La Roche AG
3. Celgene Corporation
4. Amgen Inc.
5. Novartis AG
6. Pharmacyte Biotech Inc.
7. Clovis Oncology
8. Teva Pharmaceutical Industries Ltd.
9. Pfizer Inc.
10. Merck & Co., Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports